FDA Altis 522 Update: “Mini-slings Comparable Effectiveness to Mid-urethral Slings”
“The weakness of the Altis 522 study include … high attrition rate (at 36-months, the attrition rate for the Altis arm was 23.9%, whereas the attrition rate for the Comparator arm was 40.9%)" according to the FDA Home 522 Postmarket Surveillance Studies Database. Greg Vigna, MD, JD, national mid-urethral sling attorney, states “Unfortunately the FDA [...]